Literature DB >> 3486759

Complications and pitfalls of laser therapy.

E M Mathus-Vliegen.   

Abstract

228 patients have been studied in retrospect, in an attempt to delineate the limits and pitfalls of laser treatment of benign (n = 104) and malignant (n = 124) tumors. Benign colorectal adenomas (n = 78) were divided into 3 groups according to the size of the lesion. The occurrence of complications, the persistence and recurrence rate paralleled the size of the tumor. No relationship as to the number of sessions, the interval between them or the mean and/or total amount of energy was found. The prolonged time span of treatment in larger lesions was related to the formation of large ulcers and edema. Poor accessibility and difficult positioning of the laser beam interfered with adequacy of laser treatment. In familial polyposis (n = 26) laser photocoagulation appeared a highly effective, safe and easy procedure. In esophageal cancer (n = 16), gastric (n = 13) and colorectal malignancies (n = 95) laser therapy was very efficaceous in the palliation of bleeding and/or obstruction. Unfavorable anatomy and difficult accessibility were the main drawbacks. Problems in the assessment of pathology and submucosal extension impeded effective treatment of early cancer. Generally speaking, the presence of a whitish appearance, fibrosis of bloody tissue pointed toward a less favorable response, but much more has to be learned about the interaction between laser light and tissue properties.

Entities:  

Mesh:

Year:  1986        PMID: 3486759     DOI: 10.1055/s-2007-1018415

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  2 in total

Review 1.  Complications and hazards of gastrointestinal endoscopy.

Authors:  A Habr-Gama; J D Waye
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

2.  Nd-YAG laser photoablation of sessile villous and tubular adenomas of the colorectum.

Authors:  D E Low; R A Kozarek; T J Ball; J A Ryan
Journal:  Ann Surg       Date:  1988-12       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.